| Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
|---|---|---|
| Article Number | 02019 | |
| Number of page(s) | 4 | |
| Section | Biomedical Advances and Personalized Medicine | |
| DOI | https://doi.org/10.1051/bioconf/202411102019 | |
| Published online | 31 May 2024 | |
Clinical progress of brachytherapy for cervical cancer
School of Public Health, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China
* Corresponding author: shaotch@wmu.edu.cn
Cervical cancer is a prevalent malignant tumour of the female reproductive system, posing a significant threat to women's health and lives in China. Brachytherapy is a crucial component of radiotherapy for patients with locally intermediate and advanced cervical cancer. This includes intracavitary brachytherapy, interstitial brachytherapy, intracavitary and interstitial combined brachytherapy, and radioactive seed implantation brachytherapy. The aim of this article is to provide an update on the use of intracavitary brachytherapy, interstitial brachytherapy, and radioactive particle implantation.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.